Table of Contents

June 2013, Volume 20, Number 3

Commentary

    • Rosalinda M Savoy and
    • Paramita M Ghosh

    Linking inflammation and neuroendocrine differentiation: the role of macrophage migration inhibitory factor-mediated signaling in prostate cancer

    Endocr Relat Cancer 20 (3) C1-C4, doi:10.1530/ERC-13-0133 first published on 23 April 2013
    • Eamonn R Maher

    HIF2 and endocrine neoplasia: an evolving story

    Endocr Relat Cancer 20 (3) C5-C7, doi:10.1530/ERC-13-0146 first published on 7 May 2013

Review

    • A Karpathakis,
    • H Dibra,
    • and C Thirlwell

    Neuroendocrine tumours: cracking the epigenetic code

    Endocr Relat Cancer 20 (3) R65-R82, doi:10.1530/ERC-12-0338 first published on 21 February 2013
    • Rhonda L Bitting and
    • Andrew J Armstrong

    Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

    Endocr Relat Cancer 20 (3) R83-R99, doi:10.1530/ERC-12-0394 first published on 1 March 2013
    • T J G Chambers,
    • A Giles,
    • G Brabant,
    • and J R E Davis

    Wnt signalling in pituitary development and tumorigenesis

    Endocr Relat Cancer 20 (3) R101-R111, doi:10.1530/ERC-13-0005
    • David L Vesely

    Cardiac hormones for the treatment of cancer

    Endocr Relat Cancer 20 (3) R113-R125, doi:10.1530/ERC-13-0054 first published on 26 March 2013
    • Etienne Leygue and
    • Leigh C Murphy

    A bi-faceted role of estrogen receptor β in breast cancer

    Endocr Relat Cancer 20 (3) R127-R139, doi:10.1530/ERC-12-0389 first published on 26 March 2013

Research

    • Rehan M Villani,
    • Michael J Waters,
    • and Brandon J Wainwright

    Murine basal cell carcinoma leads to tumor-mediated alterations in endocrine Igf1 signaling

    Endocr Relat Cancer 20 (3) 273-281, doi:10.1530/ERC-12-0307 first published on 12 February 2013
    • Bok-Soon Lee,
    • Hyun-Young Cha,
    • Yoo Seob Shin,
    • Yong-Sung Kim,
    • and Chul-Ho Kim

    AY4, an agonistic anti-death receptor 4 MAB, induces apoptotic cell death in anaplastic thyroid cancer cells via downregulation of Bcl-xL with reactive oxygen species generation

    Endocr Relat Cancer 20 (3) 283-291, doi:10.1530/ERC-12-0405 first published on 21 February 2013
    • Yi Li,
    • Yichun Zheng,
    • Koji Izumi,
    • Hitoshi Ishiguro,
    • Bo Ye,
    • Faqian Li,
    • and Hiroshi Miyamoto

    Androgen activates β-catenin signaling in bladder cancer cells

    Endocr Relat Cancer 20 (3) 293-304, doi:10.1530/ERC-12-0328 first published on 27 February 2013
    • Georg Hilfenhaus,
    • Andreas Göhrig,
    • Ulrich-Frank Pape,
    • Tabea Neumann,
    • Henning Jann,
    • Dietmar Zdunek,
    • Georg Hess,
    • Jean Marie Stassen,
    • Bertram Wiedenmann,
    • Katharina Detjen,
    • Marianne Pavel,
    • and Christian Fischer

    Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients

    Endocr Relat Cancer 20 (3) 305-319, doi:10.1530/ERC-12-0223 first published on 5 March 2013
    • Giovanni Luca Gravina,
    • Francesco Marampon,
    • Paola Muzi,
    • Andrea Mancini,
    • Margherita Piccolella,
    • Paola Negri-Cesi,
    • Marcella Motta,
    • Andrea Lenzi,
    • Ernesto Di Cesare,
    • Vincenzo Tombolini,
    • Emmanuele A Jannini,
    • and Claudio Festuccia

    PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer

    Endocr Relat Cancer 20 (3) 321-337, doi:10.1530/ERC-12-0240 first published on 18 March 2013
    • Sewha Kim,
    • Do Hee Kim,
    • Woo-Hee Jung,
    • and Ja Seung Koo

    Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer

    Endocr Relat Cancer 20 (3) 339-348, doi:10.1530/ERC-12-0398 first published on 18 March 2013
    • Rodrigo A Toledo,
    • Yuejuan Qin,
    • Subramanya Srikantan,
    • Nicole Paes Morales,
    • Qun Li,
    • Yilun Deng,
    • Sang-Woo Kim,
    • Maria Adelaide A Pereira,
    • Sergio P A Toledo,
    • Xiaoping Su,
    • Ricardo C T Aguiar,
    • and Patricia L M Dahia

    In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas

    Endocr Relat Cancer 20 (3) 349-359, doi:10.1530/ERC-13-0101 first published on 26 March 2013
    • Meenu Jain,
    • Lisa Zhang,
    • Mei He,
    • Ya-Qin Zhang,
    • Min Shen,
    • and Electron Kebebew

    TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma

    Endocr Relat Cancer 20 (3) 361-370, doi:10.1530/ERC-12-0403 first published on 26 March 2013
    • Ségolène Hescot,
    • Abdelhamid Slama,
    • Anne Lombès,
    • Angelo Paci,
    • Hervé Remy,
    • Sophie Leboulleux,
    • Rita Chadarevian,
    • Séverine Trabado,
    • Larbi Amazit,
    • Jacques Young,
    • Eric Baudin,
    • and Marc Lombès

    Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells

    Endocr Relat Cancer 20 (3) 371-381, doi:10.1530/ERC-12-0368
    • J R Strosberg,
    • J A Chan,
    • D P Ryan,
    • J A Meyerhardt,
    • C S Fuchs,
    • T Abrams,
    • E Regan,
    • R Brady,
    • J Weber,
    • T Campos,
    • L K Kvols,
    • and M H Kulke

    A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors

    Endocr Relat Cancer 20 (3) 383-390, doi:10.1530/ERC-12-0390 first published on 9 April 2013
    • Rosalyn D Ferguson,
    • Emily J Gallagher,
    • Dara Cohen,
    • Aviva Tobin-Hess,
    • Nyosha Alikhani,
    • Ruslan Novosyadlyy,
    • Nadine Haddad,
    • Shoshana Yakar,
    • and Derek LeRoith

    Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer

    Endocr Relat Cancer 20 (3) 391-401, doi:10.1530/ERC-12-0333 first published on 9 April 2013
    • Tobias Zellweger,
    • Susanne Stürm,
    • Silvia Rey,
    • Inti Zlobec,
    • Joel R Gsponer,
    • Cyrill A Rentsch,
    • Luigi M Terracciano,
    • Alexander Bachmann,
    • Lukas Bubendorf,
    • and Christian Ruiz

    Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naïve prostate cancer and are elevated in castration-resistant disease

    Endocr Relat Cancer 20 (3) 403-413, doi:10.1530/ERC-12-0402 first published on 11 April 2013
    • Xiang Tao,
    • Naiqing Zhao,
    • Hongyan Jin,
    • Zhenbo Zhang,
    • Yintao Liu,
    • Jian Wu,
    • Robert C Bast, Jr,
    • Yinhua Yu,
    • and Youji Feng

    FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3

    Endocr Relat Cancer 20 (3) 415-429, doi:10.1530/ERC-12-0005 first published on 11 April 2013
    • Eiji Kashiwagi,
    • Masaki Shiota,
    • Akira Yokomizo,
    • Momoe Itsumi,
    • Junichi Inokuchi,
    • Takeshi Uchiumi,
    • and Seiji Naito

    Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells

    Endocr Relat Cancer 20 (3) 431-441, doi:10.1530/ERC-12-0344 first published on 14 March 2013
    • Peter M van Koetsveld,
    • Giovanni Vitale,
    • Richard A Feelders,
    • Marlijn Waaijers,
    • Diana M Sprij-Mooij,
    • Ronald R de Krijger,
    • Ernst-Jan M Speel,
    • Johannes Hofland,
    • Steven W J Lamberts,
    • Wouter W de Herder,
    • and Leo J Hofland

    Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane

    Endocr Relat Cancer 20 (3) 443-454, doi:10.1530/ERC-12-0217 first published on 18 March 2013

Letter to the Editor

    • Alberto Cascón,
    • Lucía Inglada-Pérez,
    • Iñaki Comino-Méndez,
    • Aguirre A de Cubas,
    • Rocío Letón,
    • Jaume Mora,
    • Mónica Marazuela,
    • Juan Carlos Galofré,
    • Miguel Quesada-Charneco,
    • and Mercedes Robledo

    Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients

    Endocr Relat Cancer 20 (3) L1-L6, doi:10.1530/ERC-12-0339 first published on 12 February 2013
|

This Issue

June 2013; 20 (3)
Cover
  1. Commentary
  2. Review
  3. Research
  4. Letter to the Editor

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most